Current Issues in Molecular Biology (Jun 2023)

Whole-Exome Sequencing Identified Two Novel Pathogenic Mutations in the <i>PTCH1</i> Gene in BCNS

  • Margit Pál,
  • Éva Vetró,
  • Nikoletta Nagy,
  • Dóra Nagy,
  • Emese Horváth,
  • Barbara Anna Bokor,
  • Anita Varga,
  • László Seres,
  • Judit Oláh,
  • József Piffkó,
  • Márta Széll

DOI
https://doi.org/10.3390/cimb45070336
Journal volume & issue
Vol. 45, no. 7
pp. 5293 – 5304

Abstract

Read online

Basal cell nevus syndrome (BCNS, OMIM 109400) is a familial cancer syndrome characterized by the development of numerous basal cell cancers and various other developmental abnormalities, including epidermal cysts of the skin, calcified dural folds, keratocysts of the jaw, palmar and plantar pits, ovarian fibromas, medulloblastomas, lymphomesenteric cysts, and fetal rhabdomyomas. BCNS shows autosomal dominant inheritance and is caused by mutations in the patched 1 (PTCH1) gene and the suppressor of the fused homolog (SUFU) gene. In a few cases, variants of patched 2 (PTCH2) have been found in patients who met the criteria for BCNS. In an investigation of 11 Hungarian families who fulfilled the diagnostic criteria for BCNS, whole-exome sequencing (WES) and multiplex ligation-dependent probe amplification (MLPA) identified two novel pathogenic variants (c.2994C>A; p.Cys998Ter and c.814_818del; p.Asn272SerfsTer11), one recently identified variant (c.1737_1745del p.Val580_Val582del), and three recurrent disease-causing variants of the PTCH1 gene with a diagnosis rate of 63.6%. Disease-causing variants were not found for the SUFU and PTCH2 genes. These applied methods could not fully elucidate the genetic background of all the BCNS cases that we investigated. To uncover the missing heritability of BCNS, whole-genome sequencing or an epigenetic approach might be considered in the future.

Keywords